OncoSec Medical Incorporated (NasdaqCM:ONCS) will look for acquisitions. the company announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The company intends to use the net proceeds from this offering for (i) clinical, regulatory, manufacturing and, if and when approved, potential commercial activities of its product candidates; (ii) clinical development of our product candidates; (iii) research and development activities; (iv) potential acquisitions and in-licensing; and (v) other general corporate purposes.